Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.

Publication Year: 2023

DOI:
10.1186/s13045-023-01450-4

PMCID:
PMC10226209

PMID:
37248463

Journal Information

Full Title: J Hematol Oncol

Abbreviation: J Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe scientific boards of the ALWP of the EBMT approved this study. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no relevant conflict of interest and no competing financial interests. Competing interests The authors declare that they have no relevant conflict of interest and no competing financial interests."

Evidence found in paper:

"Funding Not applicable."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025